Orthofix International | OFIX - Sales Revenues

Stock Price
12.55
Daily Change
-0.32 -2.49%
Monthly
-1.95%
Yearly
-25.30%
Q1 Forecast
13.12

Orthofix International reported $799.49M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 72M 841K Feb/2025
Artivion USD 95.78M 2.24M Sep/2024
AtriCure USD 140.5M 6.2M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
EDAP TMS EUR 13.88M 2.16M Sep/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
J&J USD 24.6B 610M Dec/2025
Medtronic USD 9B 39M Jan/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 799.49M 602.88M Dec/2024
Plus Therapeutics USD 1.31M 73K Dec/2023
Smith & Nephew USD 3.18B 353M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Surmodics USD 29.92M 96.16M Dec/2024
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Veracyte USD 140.6M 8.7M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025